Intrinsiqq
Accuray Incorporated logo

Accuray Incorporated Insider Trading

ARAY

⊜ Compare
Last 12 months

Insiders bought 154K on the open market and sold nothing.

Net open-market
+154K
3 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
2 / 0
executives and directors
Last open-market buy
Feb 2026
Feb 20, 2026

Get an email when ARAY's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Feb 20
    Steven F Mayer
    Director · bought 54,875 at $0.56
    31K
    3.7% of stake
  • Feb 18 – 19
    Steven F Mayer
    Director · bought 195,125 at avg $0.53
    103K
    15% of stake
  • Nov 19, 2025
    Stephen R. La Neve
    CEO · bought 20,000 at $0.97
    19K
    New position
  • Jun 13, 2025
    Joseph E Whitters
    Director · bought 50,000 at $1.25
    63K
    8.9% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ARAY, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with ARAY

CompareIntrinsic value
MDXGMiMedx Group, Inc.
$3.20-1.54%18
TCMDTactile Systems Technology Inc.
$27.20+9.75%73
AORTArtivion Inc.
$26.45+11.56%29
PRCTProcept BioRobotics Corporation
$21.66+7.39%40
ANGOAngiodynamics Inc.
$12.27+4.60%40
SKINSkinHealth Systems Inc.
$11.05+6.76%42
LMATLemaitre Vascular Inc.
$87.89+9.04%72
KIDSOrthoPediatrics Corp.
$33.51+6.69%45

Held by ETFs

ARAY is in 2 US ETFs. The largest of them, with ARAY's weight in each:

Spot a number that looks wrong? Check it in ARAY's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ARAY

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.